---
title: "Chimin Health Management Co., Ltd. (603222.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/603222.SH.md"
symbol: "603222.SH"
name: "Chimin Health Management Co., Ltd."
industry: "Pharmaceuticals"
datetime: "2026-06-13T14:59:52.281Z"
locales:
  - [en](https://longbridge.com/en/quote/603222.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/603222.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/603222.SH.md)
---

# Chimin Health Management Co., Ltd. (603222.SH)

## Company Overview

Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-tube double-valve, single-tube single-valve, and single-tube double-valve soft bags; plastic bottles; and other packaging forms. It also offers medical instruments, including safety syringes, safety injection needles, sterile syringes, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other products. In addition, the company provides in vitro diagnostics products, such as clinical chemical diagnostic, immunological diagnostic, blood testing, rapid diagnostic, and enzyme-linked immunological diagnostic reagents; laboratory instruments; and in vitro diagnostic medical products, as well as FOB fecal occult blood automated immunoassay monitoring and pylori Helicobacter detection kits.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | CN Market |
| Website | [www.chimin.cn](https://www.chimin.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-06-13T04:30:08.000Z

**Overall: D (0.69)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 200 / 222 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -7.63% |  |
| Net Profit YoY | -192.32% |  |
| P/B Ratio | 3.84 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 4274742268.43 |  |
| Revenue | 668117977.86 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -20.04% | E |
| Profit Margin | -38.60% | E |
| Gross Margin | 33.66% | C |
| Revenue YoY | -7.63% | D |
| Net Profit YoY | -192.32% | E |
| Total Assets YoY | -12.55% | E |
| Net Assets YoY | -22.55% | E |
| Cash Flow Margin | 7.48% | D |
| OCF YoY | -7.63% | D |
| Turnover | 0.27 | D |
| Gearing Ratio | 47.07% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Chimin Health Management Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-7.63%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-192.32%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.84",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "4274742268.43",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "668117977.86",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-20.04%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-38.60%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "33.66%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "-7.63%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-192.32%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-12.55%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-22.55%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "7.48%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-7.63%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.27",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "47.07%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -16.58 | 186/222 | - | - | - |
| PB | 3.84 | 178/222 | 4.20 | 3.63 | 3.22 |
| PS (TTM) | 6.40 | 161/222 | 8.39 | 7.68 | 6.78 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Allist (688578.SH) | A | A | B | A | B | A |
| 02 | Xingqi Pharmaceutical (300573.SZ) | A | A | A | A | B | A |
| 03 | Hengrui Pharma (600276.SH) | A | B | C | A | B | B |
| 04 | Yunnan Baiyao (000538.SZ) | B | C | B | B | C | B |
| 05 | Haisco (002653.SZ) | A | A | B | B | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/603222.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/603222.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/603222.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/603222.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**